{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:34:47Z","timestamp":1777563287364,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,23]],"date-time":"2006-11-23T00:00:00Z","timestamp":1164240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,8,31]]},"DOI":"10.1007\/s10549-006-9444-0","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T13:52:26Z","timestamp":1164203546000},"page":"133-138","source":"Crossref","is-referenced-by-count":15,"title":["Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature"],"prefix":"10.1007","volume":"105","author":[{"given":"Alessandro M.","family":"Minisini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giada","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bergonzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpiero","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,23]]},"reference":[{"key":"9444_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1750-3639.1999.tb00226.x","volume":"9","author":"J Dalmau","year":"1999","unstructured":"Dalmau J, Gultekin HS, Posnes JB (1999) Paraneoplastic neurological syndromes: pathogenesis and physiopathology. Brain Pathol 9:261\u2013273","journal-title":"Brain Pathol"},{"key":"9444_CR2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.wco.0000169754.38944.a4","volume":"18","author":"EJ Dropcho","year":"2005","unstructured":"Dropcho EJ (2005) Update on paraneoplastic syndromes. Curr Opin Neurol 18:331\u2013336","journal-title":"Curr Opin Neurol"},{"key":"9444_CR3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/gyno.1999.5553","volume":"75","author":"Y Cao","year":"1999","unstructured":"Cao Y, Abbas J, Wu X, Dooley J et al (1999) Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. Gynecol Oncol 75:178\u2013183","journal-title":"Gynecol Oncol"},{"key":"9444_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0404.1998.tb01748.x","volume":"98","author":"J Peltola","year":"1998","unstructured":"Peltola J, Hietaharju A, Rantala I et al (1998) A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin\u2019s disease. Acta Neurol Scand 98:360\u2013363","journal-title":"Acta Neurol Scand"},{"key":"9444_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ajo.2004.01.010","volume":"137","author":"H Ohguro","year":"2004","unstructured":"Ohguro H, Yokoi Y, Ohguro I et al (2004) Clinical and immunologic aspects of cancer-associated retinopathy. Am J Ophthalmol 137:1117\u20131119","journal-title":"Am J Ophthalmol"},{"key":"9444_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0035-3787(04)70888-7","volume":"160","author":"J Newsom-Davis","year":"2004","unstructured":"Newsom-Davis J (2004) Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris) 160:177\u2013180","journal-title":"Rev Neurol (Paris)"},{"key":"9444_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ana.20221","volume":"56","author":"H Tomimitsu","year":"2004","unstructured":"Tomimitsu H, Arimura K, Nagado et al (2004) Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia. Ann Neurol 56:440\u2013444","journal-title":"Ann Neurol"},{"key":"9444_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1524-4741.2003.09514.x","volume":"9","author":"Altaha R","year":"2003","unstructured":"Altaha R, Abraham J (2003) Paraneoplastic neurological syndrome associated with occult breast cancer: a case report and review of literature. Breast J 9:417\u2013419","journal-title":"Breast J"},{"key":"9444_CR9","first-page":"216","volume":"82","author":"I Rojas-Marcos","year":"2003","unstructured":"Rojas-Marcos I, Rousseau A, Keime-Guibert F et al (2003) Spectrum of paraneoplastic neurological disorders in women with breast and gynaecologic cancer. Medicine (Baltimore) 82:216\u2013223","journal-title":"Medicine (Baltimore)"},{"key":"9444_CR10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H et al (1992) Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931\u20131937","journal-title":"Neurology"},{"key":"9444_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-9776(03)00011-0","volume":"12","author":"G Gatti","year":"2003","unstructured":"Gatti G, Sismek S, Kurne A et al (2003) Paraneoplastic neurological disorders in breast cancer. Breast 12:203\u2013207","journal-title":"Breast"},{"key":"9444_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ana.410230518","volume":"23","author":"C Budde-Steffen","year":"1988","unstructured":"Budde-Steffen C, Anderson NE, Rosenblum MK et al (1988) An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23:528","journal-title":"Ann Neurol"},{"key":"9444_CR13","volume-title":"Neurological complication of cancer. Contemporary neurology series 45","author":"JB Poser","year":"1995","unstructured":"Poser JB (1995) Paraneoplastic syndromes. In:Poser JB (ed) Neurological complication of cancer. Contemporary neurology series 45, OUP, New York"},{"key":"9444_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4615-0121-3_7","volume":"514","author":"H Ohguro","year":"2002","unstructured":"Ohguro H, Nakazawa M (2002) Pathological roles of recoverin in cancer-associated retinopathy. Adv Exp Med Biol 514:109\u2013124","journal-title":"Adv Exp Med Biol"},{"key":"9444_CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1442-9071.2001.00425.x","volume":"29","author":"C Chan","year":"2001","unstructured":"Chan C, O\u2019Day J (2001) Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Experiment Ophthalmol 29:235\u2013138","journal-title":"Clin Experiment Ophthalmol"},{"key":"9444_CR16","volume-title":"Antibodies in neurological disease, 1st edn","author":"F Folli","year":"2002","unstructured":"Folli F, Piccolo G (2002) Stiff-man syndrome: pathogenetic, nosological, and therapeutic considerations. In:Vincent A, Martino G (ed) Antibodies in neurological disease, 1st edn. Springer-Verlag, Italia, Milano"},{"key":"9444_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/115.2.495","volume":"115","author":"CE Pringle","year":"1992","unstructured":"Pringle CE, Hudson AJ, Munoz DG et al (1992) Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115:495\u2013520","journal-title":"Brain"},{"key":"9444_CR18","first-page":"1020","volume":"156","author":"P Corcia","year":"2000","unstructured":"Corcia P, Honnorat J, Guennoc AM et al (2000). Primary lateral sclerosis with breast cancer, a potential paraneoplastic neurological syndrome. Rev Neurol (Paris) 156:1020\u20131022","journal-title":"Rev Neurol (Paris)"},{"key":"9444_CR19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","volume":"41","author":"N Wakata","year":"2002","unstructured":"Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30\u00a0years retrospective study. Int J Dermatol 41:729\u2013734","journal-title":"Int J Dermatol"},{"key":"9444_CR20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","volume":"50","author":"MI Levin","year":"1998","unstructured":"Levin MI, Mozaffar T, Al-Lozi MT et al (1998) Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 50:764\u2013767","journal-title":"Neurology"},{"key":"9444_CR21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.wco.0000173462.17135.ee","volume":"18","author":"SA Rudnicki","year":"2005","unstructured":"Rudnicki SA, Dalmau J (2005) Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 18:598\u2013603","journal-title":"Curr Opin Neurol"},{"key":"9444_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","volume":"125","author":"JP Camdessanche","year":"2002","unstructured":"Camdessanche JP, Antoine JC, Honnorat J et al (2002) Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 125:166\u2013175","journal-title":"Brain"},{"key":"9444_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","volume":"22","author":"RH Quarles","year":"1999","unstructured":"Quarles RH, Weiss MD (1999) Autoantibodies associated with peripheral neuropathy. Muscle Nerve 22:800\u2013822","journal-title":"Muscle Nerve"},{"key":"9444_CR24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurologicl syndromes. J Neuro Neurosurg Psychiatr 75:1135\u20131140","journal-title":"J Neuro Neurosurg Psychiatr"},{"key":"9444_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","volume":"27","author":"CM Walko","year":"2005","unstructured":"Walko CM, Lindley C (2005) Capecitabine: a review. Clin Ther 27:23\u201344","journal-title":"Clin Ther"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9444-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9444-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:00:20Z","timestamp":1707393620000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,23]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8,31]]}},"alternative-id":["9444"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9444-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,23]]}}}